US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist
  • 54.100
  • -1.070-1.94%
Close Dec 27 16:00 ET
  • 54.100
  • 0.0000.00%
Post 20:01 ET
3.17BMarket Cap-46.24P/E (TTM)

Janux Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-82.56%439K
741.72%8.9M
-38.87%1.25M
-6.14%8.08M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
136.79%8.61M
76.05%2.85M
Operating revenue
-82.56%439K
741.72%8.9M
-38.87%1.25M
-6.14%8.08M
-13.50%2.46M
38.83%2.52M
-55.31%1.06M
28.89%2.05M
136.79%8.61M
76.05%2.85M
Cost of revenue
Gross profit
Operating expense
97.93%36.28M
4.19%22.72M
-4.10%21.41M
7.08%81.06M
-11.90%18.6M
-7.59%18.33M
11.10%21.81M
47.57%22.33M
107.03%75.7M
39.75%21.11M
Selling and administrative expenses
174.42%17.67M
13.66%7.82M
13.60%7.34M
17.42%26.14M
11.98%6.36M
5.58%6.44M
24.21%6.88M
30.67%6.46M
115.53%22.26M
44.20%5.68M
-General and administrative expense
174.42%17.67M
13.66%7.82M
13.60%7.34M
17.42%26.14M
11.98%6.36M
5.58%6.44M
24.21%6.88M
30.67%6.46M
115.53%22.26M
44.20%5.68M
Research and development costs
56.53%18.61M
-0.17%14.9M
-11.31%14.07M
2.77%54.92M
-20.69%12.24M
-13.43%11.89M
5.95%14.92M
55.78%15.87M
103.69%53.44M
38.19%15.43M
Operating profit
-126.66%-35.84M
33.38%-13.82M
0.59%-20.16M
-8.78%-72.98M
11.66%-16.14M
12.26%-15.81M
-20.20%-20.75M
-49.76%-20.28M
-103.74%-67.09M
-35.40%-18.27M
Net non-operating interest income expense
83.35%7.78M
142.69%7.86M
91.39%5.4M
264.24%14.69M
98.96%4.38M
220.14%4.25M
768.63%3.24M
2,037.88%2.82M
1,468.87%4.03M
2,874.32%2.2M
Non-operating interest income
83.35%7.78M
142.69%7.86M
91.39%5.4M
264.24%14.69M
98.96%4.38M
220.14%4.25M
768.63%3.24M
2,037.88%2.82M
1,468.87%4.03M
2,874.32%2.2M
Other net income (expense)
Income before tax
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
Income tax
Net income
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
Net income continuous Operations
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
Minority interest income
Net income attributable to the parent company
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-142.56%-28.06M
65.96%-5.96M
15.46%-14.76M
7.56%-58.29M
26.81%-11.76M
30.71%-11.57M
-3.67%-17.51M
-30.19%-17.46M
-93.01%-63.06M
-19.75%-16.07M
Basic earnings per share
-104.00%-0.51
73.81%-0.11
28.57%-0.3
13.16%-1.32
38.46%-0.24
37.50%-0.25
-2.44%-0.42
-31.25%-0.42
-9.35%-1.52
-18.18%-0.39
Diluted earnings per share
-104.00%-0.51
73.81%-0.11
28.57%-0.3
13.16%-1.32
38.46%-0.24
37.50%-0.25
-2.44%-0.42
-31.25%-0.42
-9.35%-1.52
-18.18%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -82.56%439K741.72%8.9M-38.87%1.25M-6.14%8.08M-13.50%2.46M38.83%2.52M-55.31%1.06M28.89%2.05M136.79%8.61M76.05%2.85M
Operating revenue -82.56%439K741.72%8.9M-38.87%1.25M-6.14%8.08M-13.50%2.46M38.83%2.52M-55.31%1.06M28.89%2.05M136.79%8.61M76.05%2.85M
Cost of revenue
Gross profit
Operating expense 97.93%36.28M4.19%22.72M-4.10%21.41M7.08%81.06M-11.90%18.6M-7.59%18.33M11.10%21.81M47.57%22.33M107.03%75.7M39.75%21.11M
Selling and administrative expenses 174.42%17.67M13.66%7.82M13.60%7.34M17.42%26.14M11.98%6.36M5.58%6.44M24.21%6.88M30.67%6.46M115.53%22.26M44.20%5.68M
-General and administrative expense 174.42%17.67M13.66%7.82M13.60%7.34M17.42%26.14M11.98%6.36M5.58%6.44M24.21%6.88M30.67%6.46M115.53%22.26M44.20%5.68M
Research and development costs 56.53%18.61M-0.17%14.9M-11.31%14.07M2.77%54.92M-20.69%12.24M-13.43%11.89M5.95%14.92M55.78%15.87M103.69%53.44M38.19%15.43M
Operating profit -126.66%-35.84M33.38%-13.82M0.59%-20.16M-8.78%-72.98M11.66%-16.14M12.26%-15.81M-20.20%-20.75M-49.76%-20.28M-103.74%-67.09M-35.40%-18.27M
Net non-operating interest income expense 83.35%7.78M142.69%7.86M91.39%5.4M264.24%14.69M98.96%4.38M220.14%4.25M768.63%3.24M2,037.88%2.82M1,468.87%4.03M2,874.32%2.2M
Non-operating interest income 83.35%7.78M142.69%7.86M91.39%5.4M264.24%14.69M98.96%4.38M220.14%4.25M768.63%3.24M2,037.88%2.82M1,468.87%4.03M2,874.32%2.2M
Other net income (expense)
Income before tax -142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M
Income tax
Net income -142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M
Net income continuous Operations -142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M
Minority interest income
Net income attributable to the parent company -142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -142.56%-28.06M65.96%-5.96M15.46%-14.76M7.56%-58.29M26.81%-11.76M30.71%-11.57M-3.67%-17.51M-30.19%-17.46M-93.01%-63.06M-19.75%-16.07M
Basic earnings per share -104.00%-0.5173.81%-0.1128.57%-0.313.16%-1.3238.46%-0.2437.50%-0.25-2.44%-0.42-31.25%-0.42-9.35%-1.52-18.18%-0.39
Diluted earnings per share -104.00%-0.5173.81%-0.1128.57%-0.313.16%-1.3238.46%-0.2437.50%-0.25-2.44%-0.42-31.25%-0.42-9.35%-1.52-18.18%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Intchains Group
ICG
+56.28%
SATO TECHNOLOGIES CORP
CCPUF
+2.43%
BIGG DIGITAL ASSETS INC
BBKCF
+2.20%
FRMO CORP
FRMO
-0.69%
Bitfarms
BITF
-1.81%

Unlock the Full List